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Live imaging molecular changes in junctional
tension upon VE-cadherin in zebraﬁsh
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Forces play diverse roles in vascular development, homeostasis and disease. VE-cadherin at
endothelial cell-cell junctions links the contractile acto-myosin cytoskeletons of adjacent
cells, serving as a tension-transducer. To explore tensile changes across VE-cadherin in live
zebraﬁsh, we tailored an optical biosensor approach, originally established in vitro. We
validate localization and function of a VE-cadherin tension sensor (TS) in vivo. Changes in
tension across VE-cadherin observed using ratio-metric or lifetime FRET measurements
reﬂect acto-myosin contractility within endothelial cells. Furthermore, we apply the TS to
reveal biologically relevant changes in VE-cadherin tension that occur as the dorsal aorta
matures and upon genetic and chemical perturbations during embryonic development.
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The involvement of mechanical forces and mechan-otransduction in building and maintaining the vasculatureis well appreciated. Changes in adhesive forces, ﬂuid shear,
intraluminal pressure and matrix stiffness have been shown to
have profound impacts on vascular development and home-
ostasis1–4. In the vasculature, vascular endothelial (VE)-cadherin
not only provides adhesive strength but VE-cadherin itself is
under tension5 and takes part in the endothelial mechanosensa-
tion complex, together with PECAM-1 and VEGFR2/36, 7. This
complex is required for sensing ﬂuid shear stress in endothelial
cellular monolayers and triggering the stereotypical changes in
cellular morphology and vessel structure that are seen upon
increased shear6, 7. Shear stress increases tension across PECAM-
1 through enhanced association with Vimentin5. By contrast,
increased shear in cultured cells decreases tension through VE-
cadherin. This occurs whilst endothelial cells (ECs) respond to
shear by aligning with the direction of ﬂow in culture conditions5.
Much remains to be understood about how mechanical forces in
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Fig. 1 VE-cadherin-TS is localized to cell-cell junctions and reports a differential FRET signature. a Schematic representation of the tension sensor (TS)
module. The Donor ﬂuorescent protein, Teal, is separated from the acceptor, Venus, by a stretchable linker peptide (top). When the module is under
tension (bottom), energy transfer from Teal to Venus will decrease. b Schematic of zebraﬁsh VE-cadherin-TS cDNA recombined into the ve-cadherin BAC
clone. c Venus expression from Tg(ve-cad:ve-cadTS) throughout the blood vasculature at 2 dpf. Scale bar= 150 μm. d Maximum projection of the dorsal
aorta (DA) at 3 dpf showing expression of Teal (top) and Venus (bottom) localized at cell–cell junctions. Scale bar= 10 μm. e Co-expression (Merge,
bottom) of Venus (yellow, top) from Tg(ve-cad:ve-cadTS) and Tg(ﬂi1ep:lifeact-mCherry), labeling F-actin (purple, middle), in endothelial junctions at 3 dpf.
Scale bar= 5 μm. f–g Fluorescence intensity of Venus (f) and Tg(ﬂi1ep:lifeact-mCherry), labeling F-actin (g), along a single 3 μm line-region in a single Z-
section (shown in e). h RAW FRET signal at endothelial junctions at 2 dpf. Scale bar= 5 μm. i Ratio-metric FRET signal at 2 dpf in endothelial junctions
(shown in h). Scale bar= 5 μm. j Variable ratio-metric FRET values along a single 10 μm line-region in a single Z-section in a proportion of the junction
(boxed in i)
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the vasculature are sensed in vivo, transduced and how forces
control the morphogenesis of complex vascular networks.
Currently, observing and quantifying the forces that act in cells
and tissues, including the vasculature, is a signiﬁcant technical
challenge. Studies in cultured cells have pioneered our under-
standing of how physical forces act upon cells and control bio-
logical processes. However, approaches used to measure force
in vitro such as optical and magnetic tweezers, micro-pipet
aspiration or atomic force microscopy are disruptive and are not
broadly applicable in vivo. Tension sensor (TS) technology has
introduced an optical imaging-based read-out for tension across
individual molecules in cells5, 8–10. Such imaging-based quanti-
ﬁcation of intra-molecular tension through key adhesive
molecules holds great promise for direct observation of forces
that control morphogenesis. Recent applications of functionally
validated TS-proteins for β-spectrin in Caenorhabditis elegans11
and E-cadherin in Drosophila12 have conﬁrmed the potential of
measuring intra-molecular tension changes in invertebrate
models. Nevertheless, how broadly applicable such approaches
will prove in vertebrate animal models remains to be determined.
Here we successfully applied the TS approach in the tubular
vasculature of a living vertebrate by generating a zebraﬁsh VE-
cadherin-TS strain. Our ﬁndings identify changes in VE-cadherin
tension that occur during arterial maturation, highlight key
controls for the validation of TS readouts in vivo and indicate the
utility of the approach for phenotyping in genetic and pharmaco-
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Fig. 2 VE-cadherin-TS is functional and under acto-myosin controlled tension. a Schematic representation of genetic cross to test functionality of VE-
cadherin-TS. b Wild-type (top) and ve-cadherin mutant (bottom) phenotype at 2 dpf (arrowhead indicates cardiac oedema in mutant). Scale bar= 1 mm. c
Phenotypic scoring all embryos (n= 430) collected from cross in a, showing 23% phenotypic mutants (n= 49/217) in TS-negative population (n= 217)
and 0% (n= 0/213) in TS-positive siblings (n= 213). d Phenotypic scoring of n= 286 embryos from a cross between a Tg(ve-cad:ve-cadTS)+/−,
cdh5ubs8−/−mutant and a non-transgenic cdh5ubs8+/− animal. In the TS negative population 52% (n= 76/146) displayed the mutant phenotype whilst there
were no phenotypic mutants in the TS positive clutch (n= 141). e Schematic representation of Y-27632 (ROCK inhibitor) acto-myosin inhibition. f Heatmap
image of ratio-metric FRET values in junctions of 1%DMSO and Y-27632 (45 μM/1%DMSO) treated embryos. Colors range from blue (= low FRET index/
high tension) to red (= high FRET index/low tension). Scale bar= 5 μm. g Quantiﬁcation of ratio-metric FRET values in junctions of 1 % DMSO (n= 4)
versus Y-27632 (45 μM/1%DMSO) (n= 5) treated embryos. Each data point represents a junctional region of interest (ROI), n= 33 junctions selected
from DMSO control embryos and n= 40 selected in Y-27632 treated embryos. Treatment for 5 h prior to imaging. Error bars represent
mean± s.d.; ****p< 0.0001 from unpaired two-sided Mann–Whitney test. h Heatmap image of Teal lifetime values in junctions of 1%DMSO (top) and
Y-27632 (bottom, 45 μM/1%DMSO)- treated embryos. Colors range from blue (= low lifetime/low tension) to red (= high lifetime/high tension). Scale
bar= 5μm. i Quantiﬁcation of Teal lifetime values (nano-sec) in junctions of 1 % DMSO (n= 4) versus Y-27632 (45 μM/1%DMSO) (n= 4) treated
embryos. Each data point represents a single junctional ROI, n= 25 junctions segmented from DMSO control embryos and n= 33 from Y-27632 treated
embryos. Treatment for 5 h prior to imaging. Error bars represent mean± s.d.; **p= 0.0060 from unpaired two-sided t test
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genetic perturbations. We suggest that TS readouts hold great
promise for broad application in in vivo mechanobiology studies
but that careful technical controls and validation are required.
Results
A zebraﬁsh VE-cadherin TS transgenic strain. A TS module
that contains two ﬂuorescent proteins (Teal and Venus), sepa-
rated by an elastic entropic linker peptide, forms the core com-
ponent of the approach8, 13, 14. Stretching or relaxation of the
linker can be quantiﬁed by Förster resonance energy transfer
(FRET)8, 13 (Fig. 1a). We cloned this TS module into the zebraﬁsh
VE-cadherin cDNA, between the p120-catenin and β-catenin
binding sites of the translated protein, as previously described for
mouse VE-cadherin in vitro5 (Fig. 1b, Supplementary Fig. 1a). To
express the module at levels resembling endogenous VE-cadherin,
we recombined it into a ve-cadherin BAC15 (Fig. 1b). The
transgenic line TgBAC(ve-cad:ve-cadTS)uq11bh (hereafter Tg(ve-
cad:ve-cadTS)) expressed VE-cadherin-TS at cell–cell junctions of
the vasculature and endocardium (Fig. 1c, d and Supplementary
Fig. 1b), allowing visualization of junctional VE-cadherin at
unprecedented resolution in live zebraﬁsh. VE-cadherin-TS
expression co-localized with junctional ﬁlamentous (F)-actin,
visualized by Tg(ﬂi1ep:lifeact-mCherry)uq12bh conﬁrming correct
localization of the protein (Fig. 1e–g). We could also detect a
junctional FRET signal (Fig. 1h). To correct the FRET signal for
ﬂuorescence bleed-through (BT), we generated two additional
transgenic lines, Tg(10xUAS:Teal)uq13bh and Tg(10xUAS:Venus)
uq8bh (Supplementary Fig. 1c). We used the endothelial TgBAC
(ve-cad:GALFF)15 driver to express the ﬂuorophores individually
and measure BT values for each (Supplementary Fig. 1c). This
allowed us to calculate ratio-metric energy transfer through VE-
cadherin as the ratio between BT-corrected FRET signal and
Venus ﬂuorescence, which at the same time normalizes for the
amount of VE-cadherin-TS protein (Fig. 1i,j and Supplementary
Fig. 1d). Importantly, correlation analysis comparing FRET
index values to Venus ﬂuorescence (i.e. protein expression) in
location-matched pixels within single junctions (Supplementary
Fig. 1e–h′) or in a grouped analysis of all pixels from individual
junctions (Supplementary Fig. 1i) revealed that there is no
positive correlation between FRET values and TS protein con-
centration (Supplementary Fig. 1e–i), indicating that there is no
signiﬁcant contribution of inter-molecular energy transfer16–20.
These results suggest the utility of this transgenic line to detect
local differences in VE-cadherin tension along individual cell–cell
junctions in a live vertebrate.
VE-cadherin mutants are rescued by VE-cadherin-TS. To test
functionality of the VE-cadherin-TS protein, we crossed Tg(ve-
cad:ve-cadTS) onto a ve-cadherin mutant background, cdh5(ve-
cad)ubs821. Loss of VE-cadherin function results in cardiovascular
failure21, 22. We crossed heterozygous carriers for Tg(ve-cad:ve-
cadTS)+/− and cdh5ubs8+/− to non-transgenic heterozygous car-
riers for cdh5ubs8+/− (Fig. 2a). We separated TS-positive and TS-
negative progeny at 1 dpf, prior to the onset of phenotypic
abnormalities. At 2 days post fertilisation (dpf), phenotypic
mutants can be distinguished by the appearance of cardiovascular
defects (Fig. 2b). Scoring revealed no phenotypic mutants in Tg
(ve-cad:ve-cadTS)-positive progeny (Fig. 2c). The Tg(ve-cad:ve-
cadTS)-negative siblings contained mutant phenotypes at a
mendelian ratio (Fig. 2c). Finally, Tg(ve-cad:ve-cadTS)+/−,
cdh5ubs8−/−mutant ﬁsh were adult viable (Supplementary Fig. 2a)
and crossing these to non-transgenic cdh5ubs8+/− carriers resulted
in 50% phenotypic mutants in Tg(ve-cad:ve-cadTS)-negative
progeny and no phenotypes in Tg(ve-cad:ve-cadTS)-positive
progeny (Fig. 2d). We next examined the amount of VE-cadherin
protein (by quantiﬁcation of Venus ﬂuorescence intensity) at
junctions in heterozygous and mutant animals (all Tg(ve-cad:ve-
cadTS)+/−), and we found that the gene dosage of the wild-type
VE-cadherin allele inﬂuences the amount of transgene derived
VE-cadherin at the junctions. This was observed as higher Venus
ﬂuorescent intensities, at junctions in homozygous mutants
(Supplementary Fig. 2b) This observation indicates that ECs
actively regulate functional VE-cadherin levels at their adherens
junctions and suggests that forced overexpression of TS con-
structs is unlikely to generate data reﬂecting the normal physio-
logically regulated conditions. Importantly, these results show
that VE-cadherin-TS protein can compensate for loss of endo-
genous VE-cadherin, effectively reconstituting an endogenous
protein with a synthetic TS version.
FRET in VE-cadherin-TS relies on acto-myosin contractility.
To determine if VE-cadherin-TS reports changes in acto-myosin
activity, the principal source of contractile force within cells, we
generated a negative control sensor lacking the β–catenin-binding
region of the cadherin cytoplasmic tail. This is predicted to be
incapable of sensing acto-myosin generated force (referred to as
tail less (TL)) and was previously used to verify a VE-cadherin-TS
in vitro5 (Supplementary Fig. 2c). We injected ve-cadherin-TS
and ve-cadherin-TL DNA and quantiﬁed FRET index values,
observing signiﬁcantly higher ratio-metric FRET (decreased ten-
sion) in VE-cadherin-TL compared with TS expressing junctions
(Supplementary Fig. 2d–e). However, in performing these control
experiments, we observed that forced expression of BAC DNA
frequently resulted in protein aggregation and mislocalisation for
the TL but not the TS construct, likely due to the incapacity of
this construct to bind β-catenin (Supplementary Fig. 2f–g). Fur-
thermore, the TS but not the TL construct generated stable
germline transmitted embryos despite large numbers of injected
animals being tested for the later.
As a further control for the acto-myosin contribution to TS
changes, we analysed embryos expressing the stable TS transgene
upon chemical inhibition (by Y-27632) of Rho-associated kinase
(ROCK), which is essential for acto-myosin contraction (Fig. 2e
and Supplementary Fig. 2h). We detected a reproducible
signiﬁcant increase in ratio-metric FRET in junctions of
Y-27632-treated embryos (Fig. 2f, g) as also observed in vitro5.
Treatment with Y-27632 was carefully titrated to avoid induction
of developmental defects. Therefore, while it acts to reduce acto-
myosin contractility it may not be a fully inhibitory dosage. We
further identiﬁed a signiﬁcant increase in ratio-metric FRET upon
chemical inhibition of the GTPase Cdc42, an additional regulator
of acto-myosin assembly and junctional integrity23 (Supplemen-
tary Fig. 2i–k). To control for the possibility that the changes
observed were due to the ratio-metric FRET imaging approach
being used, we measured tension changes upon Y-27632
treatment using donor ﬂuorescence lifetime measurements
(FLIM), a quantitative imaging technique that is less sensitive
to imaging or processing artifacts than the ratio-metric
approach17, 24, 25. In accordance with the ratio-metric analysis,
VE-cadherin-TS in Y-27632-treated embryos was under signiﬁ-
cantly less tension (lower Teal lifetime) compared to DMSO-
treated controls (Fig. 2h, i). Altogether these data demonstrate
that differences in energy transfer in this transgenic strain reﬂect
acto-myosin supported changes in tension through VE-cadherin
in vivo. Furthermore, these observations establish Y-27632
treatment as a suitable and reliable negative control for biological
experiments that utilize the VE-cadherin-TS strain.
VE-cadherin tension decreases in maturing DA junctions. To
test the use of this strain to report biologically informative
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changes in vessels, we examined mechanical changes at EC
junctions during artery maturation. From 2, the main axial
artery, the dorsal aorta (DA), undergoes observable morpho-
logical changes, most prominently a decrease in lumen
diameter26, 27. By visualizing VE-cadherin-TS localization over
time, we observed striking morphological changes of the EC
junctions from 2 to 4 dpf (Fig. 3a). At 2 dpf, junctions were
irregular and immature compared with junctions at 4 dpf, and
with development the junctions became progressive more linear
and aligned with the direction of blood ﬂow (Fig. 3b, c). These
cellular rearrangements have been suggested to be induced by
changes in ﬂow and are necessary for the reduction of vessel
diameter seen during maturation27. Over the period from 2 to
4 dpf, VE-cadherin-TS ratio-metric FRET measurements
reported a robust and signiﬁcant decrease in tension across VE-
cadherin (Fig. 3d, e). We further conﬁrmed this observation
using FLIM measurements, which revealed reduced intra-
molecular tension in 4 dpf linear junctions compared with
immature 2 dpf junctions (Fig. 3f, g). Of note, the differences in
FRET efﬁciency measured by FLIM were small. The efﬁciency
change for Y-27632 compared with DMSO was 1% and com-
paring 2 dpf to 4 dpf junctions was 4% (see “Methods” section).
Interestingly, cultured ECs align with the direction of ﬂow
when under shear28 and this was shown to coincide with
decreased tension through VE-cadherin5, measured by FLIM as
a 4% increase in FRET efﬁciency using a VE-cadherin-TS. This
data is in line with the efﬁciency changes measured here in
aligned, linear junctions at 4 dpf compared to immature junc-
tions at 2 dpf. In addition, previously published comparison of
a negative control construct with the VE-cadherin-TS revealed
only a 7% change in FRET efﬁciency5 measured by FLIM.
Together, these observations suggest that the dynamic range for
this VE-cadherin-TS is limited. Nevertheless, these data com-
bined demonstrate that we can measure meaningful changes in
tension through VE-cadherin in vivo. Our results indicate that
there is a correlation between the junctional rearrangements
that occur to allow DA constriction27 and mechanical changes
though VE-cadherin at the junctions.
Vegf regulates morphological and mechanical DA maturation.
Vegfr2 activity plays diverse roles in the development and func-
tion of the vasculature that include the regulation of arterial
angiogenesis, vascular permeability and junctional state29.
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Fig. 3 Cellular morphology and VE-cadherin tensile changes occur during artery maturation. a Junctional morphology of ECs in the dorsal aorta (DA)
(Venus, grey) at 2 dpf (top), 3 dpf (middle) and 4 dpf (bottom). Scale bar= 10 μm. b Junctional linearity index over time at 2 dpf (n= 37 junctions from n=
4 embryos), 3 dpf (n= 37 junctions from n= 5 embryos) and 4 dpf (n= 51 junctions from n= 4). Error bars represent mean± s.d.; 2–3 dpf **p= 0.0010;
3–4 dpf ****p< 0.0001, from unpaired two-sided Mann–Whitney test. c Junctional angle relative to the direction of blood ﬂow over time at 2 dpf (n= 53
junctions from n= 4 embryos), 3 dpf (n= 89 junctions from n= 5 embryos) and 4 dpf (n= 42 junctions from n= 4). Error bars represent mean± s.d.; 2–3
dpf **p= 0.0010; 3dpf– 4dpf ****p< 0.0001 from unpaired two-sided Mann–Whitney test. d Heatmap image of ratio-metric FRET values in junctions at 2
dpf (top), 3 dpf (middle) and 4 dpf (bottom). Colors range from blue (= low FRET index/high tension) to red (= high FRET index/low tension). Scale bar=
5 μm. e Quantiﬁcation of ratio-metric FRET values in junctions at 2 dpf (n= 54 junctional ROIs from n= 4 embryos), 3 dpf (n= 79 junctional ROIs from n=
5 embryos) and 4 dpf (n= 71 junctional ROIs from n= 4 embryos). Error bars represent mean± s.d.; 2–3 dpf ****p< 0.0001, from unpaired two-sided t
test; 3–4 dpf ****p< 0.0001 from unpaired two-sided Mann–Whitney test. f Quantiﬁcation of Teal lifetime values (nano-sec) comparing n= 43 junctional
ROIs segmented from 2 dpf embryos (n= 8) and n= 54 junctional ROIs from 4 dpf embryos (n= 10). Error bars represent mean± s.d.; ****p< 0.0001 from
unpaired two-sided Mann–Whitney test. g Heatmap image of Teal lifetime values in junctions of 2 dpf (left) versus 4 dpf (right) embryos. Colors range
from blue (= low lifetime/low tension) to red (= high lifetime/high tension). Scale bar= 5 μm
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Furthermore, together with VE-cadherin and PECAM-1, Vegfr2
takes part in the mechanosensory complex and the EC response
to ﬂow6. To investigate if interfering with Vegfr2-signaling
would inﬂuence maturation of the DA, we knocked down both
kdr and kdrl (zebraﬁsh Vegfr2 homologues) using morpholinos
(MOs) and explored the impact on the mechanical state of
junctions in the DA over time. Sub-optimal dosages were used
to inhibit arterial sprouting without affecting blood ﬂow (Sup-
plementary Fig. 3a and Supplementary Movie 1). These MOs
phenocopy demonstrated mutant phenotypes for kdr/kdrl
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= 56 junctional ROIs from n= 10 embryos). Error bars represent mean± s.d.; **p= 0.0045 from unpaired two-sided Mann–Whitney test. i Junctional
morphology of ECs in the DA (Venus, grey) at 3 dpf in 1% DMSO and SL327 (4 μM/1% DMSO) treated embryos at 3 dpf. Scale bar= 10 μm. j Ratio-metric
FRET values from uic (n= 45 junctional ROIs from n= 8 embryos) versus kdr/kdrl morphants incubated in 1% DMSO as a control (n= 43 junctional ROIs
from n= 9 embryos) and kdr/kdrl Y-27632-treated morphants (50 μM/1% DMSO, n= 40 junctional ROIs from n= 9 embryos) at 2 dpf. Error bars
represent mean± s.d.; uic–kdr/kdrlMO+DMSO ****p< 0.0001; kdr/kdrlMO+DMSO – kdr/kdrlMO+Y-27632 ***p= 0.0005 from unpaired two-sided t
test
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double mutants30 and we observed single-MO phenotypes
consistent with the reported, milder, single-mutant pheno-
types30. In this context, we observed a clear morphological
disruption of junctional maturation between 2–3 dpf (Fig. 4a, b)
and an increased number of ECs in the DA (Fig. 4c). Interest-
ingly, we observed increased VE-cadherin tension in these
immature junctions (Fig. 4e, f). The downstream effector of
Vegfr2 signaling in developing zebraﬁsh arteries is Erk31 and so
to independently validate the observed changes, we turned to
inhibition of Erk signaling. Treatment with the MEK inhibitor
SL327, which blocks Erk phosphorylation in arteries31, from 20
h post fertilisation (hpf) to 3 dpf also resulted in reduced line-
arity and increased VE-cadherin tension at 3 dpf (Fig. 4g–i).
Interestingly, this treatment resulted in a milder effect on
arterial angiogenesis when compared to the kdr/kdrl double
morphants (Supplementary Fig. 3a,b), yet still impacted upon
junctional maturation and VE-cadherin tension. Importantly,
increased tension upon Vegfr2 depletion required acto-myosin
activity, since Y-27632 treatment of double morphants lowered
VE-cadherin tension (Fig. 4j). Overall, manipulating the normal
process of maturation by reducing Vegfr2 or downstream Erk
signaling during development leads to disorganized junctions
that display increased tension through VE-cadherin. These
observations further conﬁrm the utility of the TS line to analyse
sub-cellular changes in functional vessels in vivo; both increases
and decreases in intra-molecular tension across VE-cadherin.
Acute loss of ﬂow does not alter tension upon VE-cadherin.
The most well-studied forces that regulate vascular development
and disease are those generated by blood ﬂow. Lumenal ﬂow
generates shear stress and pressure, which control EC state and
signaling4. To study if loss of blood ﬂow might affect VE-cadherin
tension, we ﬁrst took advantage of the most commonly used loss-
of-ﬂow model in zebraﬁsh, by injecting silent heart (sih) targeting
MOs32. However, we found this model unsuitable since the ECs
of the DA were severely disrupted and junctions failed to form
without initial establishment of embryonic blood ﬂow (Supple-
mentary Fig. 4a). Alternatively, we blocked cardiac contraction
after the arterial network had formed under normal ﬂow condi-
tions. We applied a high dose (800 mg/ml) of the anesthetsic
tricaine (3-amino benzoic acid ethyl ester) to 3 dpf embryos,
sufﬁcient to stop contraction and thus ﬂow. After 3 h without
ﬂow, ratio-metric FRET imaging revealed that tension through
VE-cadherin was unchanged (Supplementary Fig. 4b, c). Fur-
thermore, we surgically disconnected the outﬂow tract of 3 dpf
embryos to stop blood ﬂow and again VE-cadherin tension did
not signiﬁcantly change compared with control siblings
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Fig. 5 Calcium signaling maintains lower VE-cadherin tension during artery maturation. a Heatmap image showing average intensity projection of ﬂi1a-
driven GCaMP5G expression (indicating calcium) in the DA at 2 dpf (left) and 4 dpf (right). Colors range from black (= low calcium) to white (= high
calcium). Scale bar= 10 μm. b Increase in ﬂuorescence intensity index (= ﬂi1a driven GCaMP5G/ ﬂi1a-driven RFP) in the dorsal wall of the DA of n= 9
embryos imaged at 2 and 4 dpf. **p= 0.0012, from paired t test. c Junctional morphology of ECs in the DA (Venus, grey) of a 0.5% DMSO, a 15 μM/0.5%
DMSO Nifedipine and a 25 μM/0.5% DMSO Nifedipine treated embryo at 4 dpf. Treatment from 2 to 4 dpf. Scale bar= 10 μm. d Ratio-metric FRET values
in junctions of 0.5% DMSO (n= 42 junctional ROIs from n= 5 embryos), 15 μM Nifedipine (n= 54 junctional ROIs from n= 6 embryos) and 25 μM
Nifedipine (n= 59 junctional ROIs from n= 6 embryos) treated embryos. Treatment was from 2 to 4 dpf. Error bars represent mean± s.d.; DMSO – 15 μM
Nifedipine **p= 0.0068, DMSO – 25 μM Nifedipine ****p< 0.0001, from unpaired two-sided Mann–Whitney test.e Junctional linearity index in 0.5%
DMSO treated controls (n= 5) versus 25 μM Nifedipine-treated embryos (n= 6). Each data point represents a junction, n= 18 control junctions measured
and n= 18 junctions from Nifedipine-treated embryos. Error bars represent mean± s.d.; not signiﬁcant (ns) p= 0.8147, from unpaired two-sided
Mann–Whitney test. f Ratio-metric FRET values quantiﬁed from 1% DMSO-treated controls (n= 39 junctional ROIs from n= 6 embryos), BAPTA-AM-
treated (100 μM for 1 h, n= 58 junctional ROIs from n= 8 embryos), Nifedipine-treated (50 μM for 30min, n= 27 junctional ROIs from n= 5 embryos) and
Nifedipine + Y-27632-treated embryos (n= 47 junctional ROIs from n= 8 embryos). Error bars represent mean± s.d.; 1% DMSO – 100 μM BAPTA-AM *p
= 0.0498; 1% DMSO – 50 μM Nifedipine ****p< 0.0001; 50 μM Nifedipine - 50 μM Nifedipine + 50 μM Y-27632 ***p= 0.0008, from unpaired two-sided
t test
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(Supplementary Fig. 4d–e). Finally, 50 mM 2,3-butanedione
monoxime (BDM, a myosin ATPase inhibitor) at 2 dpf, a stage
when VE-cadherin is under higher tension, did not alter VE-
cadherin tension (Supplementary Fig. 4f–g). We have reported
that VE-cadherin tension decreases from 2 to 4 dpf, as ﬂow
patterns have been reported to change27, 33, a phenomenon that
was also observed after induction of shear stress over an EC
monolayer5. The failure to detect changes in VE-cadherin tension
when ﬂow was acutely disrupted might indicate changes that are
below the detection limit using this TS system. Alternatively, the
ongoing role of ﬂow upon junctions of the DA may represent
only a minor contribution relative to the changes induced over a
longer developmental period by cellular rearrangements regulated
by acto-myosin contractile forces.
Calcium signaling maintains low VE-cadherin tension. Endo-
thelial calcium signaling is required for ongoing vascular mor-
phogenesis in zebraﬁsh34 and is important for cellular
homeostasis35–37 and acto-myosin function38, 39. We therefore
asked if the levels of intra-cellular calcium contribute to arterial
maturation. We ﬁrst assessed calcium levels in the DA from 2 dpf
to 4 dpf using a Tg(ﬂi1a:GALFF) driver combined with UAS:RFP
and UAS:GCaMP5G (a calcium reporter40, 41). We found that
during DA maturation, intra-cellular calcium increases, measured
as the normalized index of GCaMP5G/RFP (Fig. 5a, b). To test if
this increase in calcium plays a role in junctional maturation, we
reduced EC intra-cellular calcium by treating embryos with the
calcium channel antagonist Nifedipine42–46. Nifedipine treatment
from 2 to 4 dpf resulted in a signiﬁcant, concentration dependent,
increase in VE-cadherin tension (Fig. 5c, d). Interestingly, these
treatments did not affect junctional linearity (Fig. 5e). We further
found that a higher dose of Nifedipine (50 μM) for 30 min at 3
dpf resulted in an immediate increase in VE-cadherin tension,
which was prevented when ROCK was inhibited with Y-27632
(Fig. 5f). In addition, independent treatment with the intra-
cellular calcium chelator BAPTA-AM in a pulsed experiment also
increased VE-cadherin tension rapidly, similar to Nifedipine
(Fig. 5f). These results demonstrate that calcium signaling in the
DA increases during vessel maturation and is required for
reduced tension through VE-cadherin. Importantly, the obser-
vation that calcium signaling inhibition leads rapidly to increased
tension suggests that calcium plays an active, ongoing role to
maintain low tension across junctional VE-cadherin during artery
maturation.
Discussion
This study shows that TS technology is applicable in a complex
vertebrate vasculature. To our knowledge, this strain represents
the ﬁrst functionally tested, tissue restricted TS system demon-
strated to measure tensile changes in a vertebrate. Hence, we
expand on previous overexpression of an α-actinin-TS in frog-
s47and highlight the potential for translation of tension biosensors
to other vertebrates, tissues, cellular structures and disease
models. The line provides a tool to visualize VE-cadherin
dynamics in great detail. Importantly, changes in energy trans-
fer across zebraﬁsh VE-cadherin-TS proteins is a reliable proxy
for acto-myosin controlled tension through VE-cadherin. Hence,
this line can be applied to study mechanical changes during
vascular morphogenesis, in mutant models for cardio-vascular
diseases or using pharmacological approaches.
Using VE-cadherin-TS as a junctional marker, we identiﬁed a
correlation between changes in junctional morphology and
decreased tension across VE-cadherin as arterial junctions mature
in vivo, similar to what has been reported when ﬂow was applied
to cultured cells in vitro5. Over time, aortic EC junctions become
more linear and align with the direction of blood ﬂow, resulting
in more elongated ECs and reduced tension through VE-
cadherin. We also saw that when Vegfr2 or Erk signaling is
reduced, junctions fail to linearize, remain disorganized (imma-
ture) and remain under higher VE-cadherin tension. These
mechanical changes probably relate to the dynamic state of
junctions during vessel morphogenesis, which has been pre-
viously shown to be regulated by Vegfr-signaling levels29. Inter-
estingly, between 2 and 3 dpf, this process of cellular
rearrangement during artery maturation has been correlated with
changes in ﬂow patterns and is thought to be regulated by ﬂow27.
Nevertheless, we found that a complete loss of blood ﬂow for a
period of 3 h at 2 and 3 dpf has no inﬂuence on VE-cadherin
tension. This may indicate that the mechanical changes control-
ling EC junctional maturation, if regulated by ﬂow, become
established over a longer developmental timeframe during
maturation and that ﬂow plays little role in maintenance of
tension through VE-cadherin. Future analyses in mutants models
such as the recently described endoglin-deﬁcient model27, in
which the dorsal aorta fails to mature, resulting in patterned ﬂow
defects, may help to reveal how tension changes observed across
VE-cadherin contribute to these stereotypical cellular rearrange-
ments during arterial maturation.
We further identify an increase in intra-cellular calcium in
maturing ECs, which correlates with the process of DA matura-
tion from 2 to 4 dpf. We ﬁnd that acutely reducing calcium sig-
naling leads to immediate increases in VE-cadherin tension.
Hence, unlike ﬂow, calcium signaling maintains the junctional
mechanical state as measured at the level of VE-cadherin tension.
In zebraﬁsh, the initiation of blood ﬂow triggers endothelial cal-
cium signaling, which is required for ongoing vascular morpho-
genesis34. Likewise, changes in ﬂow conditions that occur during
maturation27, 33 could open endothelial calcium channels, thereby
increasing intra-cellular calcium over time. Inside the cells, cal-
cium probably facilitates reduced VE-cadherin tension by mod-
ulating the distribution of acto-myosin tension away from VE-
cadherin at cell–cell junctions. Our work hence identiﬁes a
number of factors that contribute to tension changes across VE-
cadherin during arterial maturation. Our data suggests that as the
DA matures changes in junctional morphology, cellular orienta-
tion, calcium signaling levels, and contractile tension across VE-
cadherin deﬁne the maturation process. Importantly, these stu-
dies of DA maturation demonstrate the utility of the TS model in
one speciﬁc setting, and highlight the promise of this approach
more broadly.
It is important to note several observations that should inﬂu-
ence similar, future studies. The use of FRET imaging in vivo is
technically challenging and could produce spurious biological
conclusions if not carefully controlled. We have used well-deﬁned
controls and ﬁnd that both technical imaging controls and bio-
logical controls are needed to ensure conﬁdence. Speciﬁcally, to
demonstrate that TS measurements reﬂect biological changes
rather than imaging modality, we here used both ratio-metric and
lifetime FRET imaging for key observations (e.g., tension changes
in wild-type embryos during maturation and upon Y-27632
treatment). We also used multiple related genetic and chemical
treatments to validate key observations (e.g., Y-27632 and Cdc42
inhibition; kdr/kdrl MO knockdown and SL327 treatment; Nife-
dipine and BAPTA-AM treatment; Tricaine, BDM and surgical
blockage of ﬂow). Furthermore, Y-27632 treatment served as an
ideal negative control setting for treatments that caused increased
tension through VE-cadherin (e.g., Vegfr2 depletion and Nife-
dipine treatment). More difﬁcult to use in vivo was the VE-
cadherin TL control construct that produced VE-cadherin lacking
the β-catenin-binding domain and therefore unable to bind to the
acto-myosin cytoskeleton. We found that junctional TL did
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report higher FRET measurements (i.e., less tension); however,
use of the construct was compromised because in many cases it
mislocalized in the cell. This is likely due to the β-catenin-binding
domain being required for efﬁcient VE-cadherin localization, as
supported by recent studies in Drosophila48. Thus, it is possible
that such negative control constructs are unreliable and we sug-
gest chemical inhibition of endogenous acto-myosin contractility
serves as a more reliable negative control. We further noted above
that FRET efﬁciency changes measured by lifetime were limited
for this particular TS. We expect that ongoing optimization of TS
modules with different force sensitivities11, 13, 14 as well as
improved sensitivity in microscopy in the future will allow us to
improve this and to quantify intra-molecular tension and con-
tractile force with increasing sensitivity. Finally, by analyzing VE-
cadherin-TS on a VE-cadherin-mutant background and expres-
sing it from a large BAC clone that appears to recapitulate normal
gene regulation, we found that the TS protein could functionally
compensate for loss of endogenous VE-cadherin. In the homo-
zygous mutant context, we also observed VE-cadherin-TS
expression at higher levels than in the presence of wild-type
VE-cadherin, indicating accurate cellular regulation of VE-
cadherin levels (Supplementary Fig. 2b). This increased expres-
sion is expected to improve image resolution, sensitivity, and
more accurately reﬂect endogenous protein levels. We conclude
that replacing the endogenous protein in such a manner is an
ideal approach, superior to forced overexpression and recom-
mended for future studies. Overall, the approaches and ﬁndings
presented here highlight the utility of TS approaches in vivo and
will help to support future studies into the physical forces con-
trolling functional and developing tissues.
Methods
Zebraﬁsh husbandry and strains. All animal work adhered to the guidelines of
the animal ethics committee at the University of Queensland. Published transgenic
lines and mutants used for this work are Tg(ﬂi1a:GALFF)ubs3 49, Tg(10.5xUAS:
GCaMP5G)uq2Tg 41, Tg(10xUAS:Venus)uq8bh50 and cdh5(ve-cad)ubs8 21. Tg(5xUAS:
RFP)nkuasrfp1a was kindly provided by the Bakkers laboratory. All embryos were
analysed before sexual maturity thus sex-speciﬁc differences can be excluded.
VE-cadherin TS and VE-cadherin TL cloning and BAC recombineering. To
construct ve-cadherin Tension Sensor (TS) and ve-cadherin Tail Less (TL) cDNAs
we initially replaced eGFP in pEGFP-N1 by the TS module sequence8 using XhoI
and NotI with In-fusion HD cloning technology. We generated two plasmids using
this approach, one harboring a TS module without a stop codon (pN1-TS, for ve-
cadherin TS) and one harboring a TS module with a stop codon (pN1-TS-stop, for
ve-cadherin TL). We subsequently ampliﬁed the ve-cadherin “head” and “tail”
domains of zebraﬁsh ve-cadherin using a full-length clone (MGC:194987) as a
template. The “head” domain includes the extracellular, transmembrane and p120-
catenin domains of zebraﬁsh ve-cadherin (Fig. 1b and Supplementary Fig. 1a). The
“tail” includes the β-catenin-binding domain (Fig. 1b). The β-catenin-binding
domain is absent in the VE-cadherin Tail Less negative control (Supplementary
Fig. 2c).
Primers used for “head” and “tail” domain ampliﬁcation: ve-cad-head-
Forward:5′-GGACTCA GATCTCGAGCGCCACCATGATGAAACAGTGTGCC
AG-3′
(infusion homology arm= bold, kozak sequence underlined)
ve-cad-head-Reverse: 5′-TGCTCACCATCTCGAGATCTCGATCACGATCTG
CC-3′
(infusion homology arm= bold)
ve-cad-tail-Forward: 5′-CTGTACAAGGCGGCCGCTGGCATTCCCTATGAC
ACATTAC-3′
(infusion homology arm= bold)
ve-cad-tail-Reverse: 5′-TCTAGAGTC GCGGCCGCTCAGTAGGAGCTATCC
GAATC-3′
(infusion homology arm= bold)
For ve-cadherin TS cDNA, the “head” domain was placed upstream of the TS
module and the “tail” sequence was placed downstream of the TS module by
infusion cloning at the XhoI and NotI restriction sites in pN1-TS making pN1-ve-
cadTS. For ve-cadherin TL cDNA the “head” domain was placed upstream of the
TS module by infusion cloning at the XhoI restriction site in pN1-TS-stop, making
pN1-ve-cadTL. To generate inserts for BAC recombineering we ampliﬁed ve-
cadherin TS (from pN1-ve-cadTS) and ve-cadherin TL (from pN1-ve-cadTL)
including a Kanamycin resistance cassette using the following primers:
ve-cad-BAC insert-Forward: 5′-ctacaaggcatgaattatcatacagatatttgttttgttgttttc
tgcagATGATGAAACAGTGTGCCAGAAGG-3′ (homology arm= bold)
kanamycin-Reverse: 5′-ACAGCAACCCTGAAGACAGGCTCAGTCATCT
GCCTTCTGGCACACTGTTTTCAGAAGAACTCGTCAAGAAGGCG-3′
(homology arm= bold)
We replaced the ﬁrst two amino acids (ATGATG) of ve-cadherin on the CH73-
357K2 BAC clone15 with ve-cadherin-TS-kanamycin and ve-cadherin-TL-
kanamycin inserts generating two BAC clones vecad:vecadTS and ve-cad:ve-cadTL
(Supplementary Fig. 2c). Two Tol2 LTRs ﬂanking an ampicillin resistance cassette
were placed in the BAC vector backbone using RedET assisted recombination as
previously described15.
Gateway cloning. Teal and Venus were cloned into the Gateway pME vector
(pDON-221) using Gateway technology51.
Primers used:- pME-Teal and Venus-Forward: 5′-GGGGACAAGTTTGTACA
AAAAAGCAGGCTatggtgagcaagggcgaggag-3′ (gateway homology arm= bold) -
pME-Teal and Venus-Reverse: 5′-GGGGACCACTTTGTACAAGAAAGCTG
GGTActacttgtacagctcgtccatg-3′ (gateway homology arm= bold)
Subsequently a Gateway LR reaction was performed combining a p5E-10xUAS,
pME-Teal or pME-Venus and p5E-polyA placing the ﬁnal 10xUAS:Teal and
10xUAS:Venus sequence into pDestTol2pA2AC (containing the α-crystallin
promoter driving GFP in the zebraﬁsh lens).
ﬂi1ep:lifeact-mCherry plasmid DNA was a kind gift from Holger Gerhardt and
Li-Kun Phng.
Transgenesis. To establish Tg(ve-cad:ve-cadTS)uq11bh 1 nl of puriﬁed BAC DNA
was injected at 100 ng/μl into single-cell stage embryos together with tol2 trans-
posase mRNA (25 ng/μl). Embryos expressing VE-cadherin-TS mosaically were
selected and raised to adulthood and screened for germline transmission to gen-
erate a stable transgenic line.
To establish Tg(ﬂi1ep:lifeact-mCherry)uq12bh and Tg(10xUAS:Teal)uq13bh 1 nl of
circular plasmid DNA was injected at 50 ng/μl into single cell stage embryos
together with tol2 transposase mRNA (25 ng/μl). Embryos expressing either β-
crystallin:mKate2 (in backbone of ﬂi1ep:lifeact-mCherry DNA) or α-crystallin:GFP
(in backbone of 10xUAS:Teal DNA) in the eyes were raised to adulthood and
screened for germline transmission to generate stable transgenic lines.
Experimental design VE-cadherin-TS rescue experiment. At 1 day post ferti-
lization (dpf), when homozygous mutants are phenotypically indistinguishable
from siblings, embryos were separated in two populations; Tg(ve-cad:ve-cadTS)-
positive and Tg(ve-cad:ve-cadTS)-negative embryos. We subsequently quantiﬁed
the number of embryos that represented either a wild-type or cdh5ubs8−/− mutant
phenotype at 2 dpf (Fig. 2b). The Tg(ve-cad:ve-cadTS)-positive embryos were raised
to adulthood and we veriﬁed that Tg(ve-cad:ve-cadTS)+/−, cdh5ubs8−/− mutant ﬁsh
are adult viable as crossing these to non-transgenic cdh5ubs8+/− carriers resulted in
52% phenotypic mutants in Tg(ve-cad:ve-cadTS) negative clutches using the same
experimental design (Fig. 2d).
Chemical treatments. For Y-27632 (ROCK inhibitor) treatments embryos were
incubated in E3 medium containing 45 μM Y-27632 in 1% DMSO or 1% DMSO
only as a negative control for 5 h at 3 dpf.
For ML-141 (Cdc42 inhibitor) embryos were incubated in E3 medium
containing 50 μM ML-141 in 0.5% DMSO or 0.5% DMSO in E3 as a negative
control for 5 h at 3 dpf.
Nifedipine (calcium channel inhibitor) was added at 15 and 25 μM in 0.5%
DMSO in E3 medium from 2 dpf to 4 dpf. 0.5% DMSO in E3 was applied as a
negative control over the same time course. For acute treatments at higher dose,
Nifedipine was added at 50 μM in 1% DMSO with 1% DMSO only as a control.
Embryos were treated for 30 min at 3 dpf. Embryos were treated with the cell-
permeable calcium chelator BAPTA-AM (100 μM) in 1% DMSO with 1% DMSO
only as a control for 1 h.
For SL327 (MEK inhibitor) treatments embryos were incubated in 4 uM SL327
in 1%DMSO or in 1% DMSO as a negative control from 20 hpf till 3 dpf. For
imaging at 3 dpf embryos with intact blood circulation were selected for ratio-
metric FRET imaging.
To stop blood ﬂow, we applied Tricaine at 800 mg/ml in E3 medium to 3 dpf
embryos, which immediately stopped cardiac contraction and we used the myosin
ATPase inhibitor 2,3-butanedione monoxime (BDM) at 50 mM to stop contraction
at 2 dpf.
Morpholino injections. To prohibit cardiac contraction, we made use of a pre-
viously published morpholino targeting silent heart/tnnt2a32. To reduce Vegfa
signaling, we injected published morpholinos against kdr and kdrl (1 ng each)52, 53.
We optimized the kdr and kdrl morpholino reagents to achieve a partial loss of
Vegfr2 function since complete loss of function as seen in kdr/kdrl double
mutants30, would result in cardiac defects and loss of blood circulation. At 2 dpf,
we selected morphant embryos that had not formed intersegmental vessels (ISVs)
but did have intact cardiac function and blood circulation (Supplementary Fig. 3a
and Supplementary Movie 1).
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01325-6 ARTICLE
NATURE COMMUNICATIONS |8:  1402 |DOI: 10.1038/s41467-017-01325-6 |www.nature.com/naturecommunications 9
Genotyping cdh5ubs8 allele in Tg(ve-cad:ve-cadTS) animals. To distinguish the
wild-type ve-cadherin sequence within the BAC transgenic insertion from the
endogenous ve-cadherin locus in Tg(ve-cad:ve-cadTS) embryos analysed in Sup-
plementary Fig. 2b, we designed primers to speciﬁcally amplify a genomic region
ﬂanking the mutation site of cdh5ubs8. The PCR-ampliﬁed products were subse-
quently digested for 1 h at 60 °C using BsaBI, which cuts once in the wild-type
allele and twice in the mutant (ubs8).
Primers used: ubs8 in TS – Forward: 5′- ACAGTGTGTTTGCATCATTG-3′
ubs8 in TS – Reverse: 5′-ACAGTCTTGGTGTTACCATTGGG-3′.
Post-acquisition analysis of ratio-metric FRET values. All FRET imaging was
performed on Zeiss 710 FCS confocal microscopes using line-sequential scanning
and GaAsP high sensitivity detectors.
Image settings were optimized for Tg(ve-cad:ve-cadTS) expression for every
imaging session and then Tg(ve-cad:GALFF); Tg(10xUAS:Teal)- and Tg(ve-cad:
GALFF); Tg(10xUAS:Venus)-positive embryos were imaged with the same settings
(Supplementary Fig 1c). We used a custom-written Matlab (MathWorks) script54
to measure nonlinear Donor BT (DBT) and Acceptor BT (ABT) constants from Tg
(ve-cad:GALFF); Tg(10xUAS:Teal) and Tg(ve-cad:GALFF); Tg(10xUAS:Venus)
images. All pixel intensities for both Teal and Venus in the images acquired from
Tg(ve-cad:ve-cadTS) embryos that fell outside the conﬁdence boundaries applied to
measure DBT and ABT were excluded from the analysis by applying a MASK. As
such, we processed only those RAW FRET-expressing pixels for which Donor and
Acceptor intensities allowed the precise calculation of DBT and ABT constants. All
processing to generate FRET index values was performed using ImageJ 1.47
(National Institutes of Health, USA) software on mean or median ﬁlter-adjusted
RAW images. The ﬁnal FRET index represents a BT-corrected FRET divided by
Acceptor (Venus) intensity in each pixel (order of imaging processing is
represented in Supplementary Fig. 1d).
Junctional linearity index quantiﬁcation. Junctional linearity (Figs. 3b, 4d, h, and
5e) was quantiﬁed using ImageJ 1.47 (National Institutes of Health, USA) software.
We generated maximum intensity projections of the Venus signal from Tg(ve-cad:
ve-cadTS)-positive embryos. We projected one half of the dorsal aorta (DA) so that
there would be no interference of junctional expression from junctions located at
the other half. We selected only those junctions for which we could identify the
vertices within the projection of the DA. Using the Straight-line tool, we measured
the length in μm between the vertices. Then, using the Freehand-line tool, we
measured the length of the junction in μm. The junctional linearity index was
calculated by dividing the distance between junctional vertices over the length of
the junction. The closer to 1 in the index, the straighter the junction.
Quantiﬁcation of junctional angles relative to ﬂow. Quantiﬁcations of the angle
of junctions relative to blood ﬂow (Fig. 3c) was performed using ImageJ 1.47
(National Institutes of Health, USA) software. We generated maximum intensity
projections of the Venus signal from Tg(ve-cad:ve-cadTS)-positive embryos and
selected only those junctions for which we could identify the vertices within the
projection of the DA. We projected one half of the DA so that there would be no
interference of junctional expression from junctions located at the other half. Using
the Staight-line tool, a reference line was drawn through the middle of the vessel to
indicate the direction of blood ﬂow. For each junction, the Angle-tool was applied
to draw the angle between the reference line of ﬂow and the direction of the
junction and measured angles were noted. The smaller the angle, the more the
junction is aligned to ﬂow.
Quantiﬁcations of the number of ECs in the dorsal aorta. To quantify the
number of ECs in the DA (Fig. 4c), we used the junctional expression of Venus
from Tg(ve-cad:ve-cadTS) to identify the cell–cell junctions and thus select indi-
vidual cells. We generated maximum intensity projections of a ~ 213 μm long
fragment of the DA. We projected one half of the DA so that there would be no
interference of junctional expression from junctions located at the other half. The
Multipoint-tool in ImageJ 1.47 (National Institutes of Health, USA) was applied to
mark each cell and these were saved as ROIs.
Post-acquisition analysis of GCaMP5G expression. Imaging of Tg(ﬂi1a:GALFF);
Tg(10.5xUAS:GCaMP5G); Tg(5xUAS:RFP) embryos was performed on a Zeiss 710
FCS confocal microscopes using GaAsP detectors. The same embryos were imaged
at 2 and 4 dpf, and the image settings were kept constant. All images were ﬁlter
mean= 1 adjusted in ImageJ 1.47 (National Institutes of Health, USA) and the RFP
expression was used to make a binary MASK of the endothelial expression. The
GCaMP5G expression was subsequently divided over the RFP expression present
within the MASK region to generate the ﬁnal GCaMP5G/RFP index. The index
measurements were collected from 5 slices of the dorsal wall of the DA in each
embryo. The average of the ﬁve slices was noted as the ﬁnal GCaMP5G/RFP index
value (Fig. 5b).
Correlation analysis of Venus intensity and ratio-metric FRET. For pixel-
matched correlation analysis, we used the line-tool in ImageJ 1.47 (National
Institutes of Health, USA) to draw lines across the middle of the junctions and then
plotted the intensity proﬁles of both Venus ﬂuorescence intensities and ratio-
metric FRET values present in the pixels across these lines. These proﬁles are
shown in Supplementary Fig. 1e–h. Correlation plots of these pixel-matched values
are shown in Supplementary Fig. 1e′–h′. In addition to the pixel-matched analysis,
a grouped analysis was performed of all pixels within all junctions ROIs (n= 52)
from different ﬁsh (n= 10) at 4 dpf (Supplementary Fig. 1i). First junctional pixels
were isolated using a binary MASK in ImageJ 1.47 (National Institutes of Health,
USA) based on Venus ﬂuorescence. Subsequently, all pixels were grouped based on
increments of Venus ﬂuorescence intensity levels of 500 (group1: 7750-8250,
group2: 8250-9750, group3: 9750-10250 …… and group28: 35250–35750). The
mean FRET index and S.E.M of pixels that belong to a Venus intensity window
were calculated and plotted for each Venus intensity group as a function of the
Venus intensity.
Grouped analysis of pixel distribution across intensity groups. To compare the
ﬂuorescence intensity levels of Venus in junctions from heterozygous ubs8+/− and
homozygous ubs8−/−-mutant embryos (all Tg(ve-cad:ve-cadTS)+/−) (Supplemen-
tary Fig. 2b), we quantiﬁed the number of junctional pixels within groups separated
by increments of Venus intensity of 1000; group1: 6000–7000 (mean= 6000),
group2: 7000–8000 (mean= 7500), group3: 8000–9000 (mean= 8500) ……
group41: 47000–48000 (mean = 47500). Junctional pixels were selected by making
a binary MASK in ImageJ 1.47 (National Institutes of Health, USA) based on
Venus ﬂuorescence. The number of pixels per group was plotted against the mean
Venus ﬂuorescence intensity for that group (e.g., mean= 6000, 7500, 8500, etc).
FLIM-FRET imaging and processing. The data for FLIM (Figs. 2h, i, and 3f, g)
was acquired using an HC PL APO CS2 40 × 1.1 NA water objective on an inverted
DMI 6000 SP8 confocal microscope (Leica Microsystems). The excitation source
was a Ti:Sapphire femtosecond laser cavity (Chameleon Vision II, Coherent),
operating at 80 MHz and tuned to a wavelength of 870 nm for Teal excitation.
Intensity was recorded with HyD detector (Leica Microsystems) in the non-
descanned (NDD) position (520/40 nm). The FLIM data were recorded using a
Picoharp 300 TCSPC system with Symphotime software (Picoquant). Images of
512 × 512 pixels were acquired with a line rate of 600 Hz. The pixel dwell time was
0.8 μs, and images were integrated until 200-300 photons per pixel were acquired.
All processing of the RAW FLIM data was performed using FLIMﬁt software55
version 5.0.1 (kindly provided by Dr Sean Warren). First, to select reads from the
junctions and exclude background counts, junctional regions were segmented.
Subsequently the segmented images were smoothed using a 3 × 3 pixel kernel and
the mean lifetime per junctional region was calculated from a single exponential ﬁt
to the ﬂuorescence decay data using a Maximum Likelihood estimator. The pixels
in each junction were averaged to give a single lifetime value (one data point= one
junction). Pixels below the background levels of intensity are set to black in the
color-mapped images and within junctions blue is low lifetime and red is high
lifetime. The mean FRET efﬁciencies (E) measured by FLIM were calculated by
dividing the mean Teal lifetime values by the published lifetime of Teal56 (2.65
nano-sec) in the following equation: E= 1-(mean Teal lifetime/2.65).
Statistical analysis. Prism software (GraphPad) was used for all statistical analysis
(t tests and Mann–Whitney-tests). D’Agostino–Pearson test was applied to test
normal distribution of the data points. When the data were normally distributed a
Student’s t test was used for comparison of two means. When the data did not
follow a normal distribution, the Mann–Whitney test was used for comparison of
two means. The threshold for signiﬁcance was taken as p< 0.05 and all the data are
represented as mean± s.d. For each experimental comparison, embryos were
randomly distributed and sibling matched, therefore each embryo can be con-
sidered as a biological replicate. No statistical methods were used to predetermine
sample sizes, but our sample sizes are comparable to those reported recently for
analysis of junctional dynamics in zebraﬁsh27, 57.
Data availability statement. All the relevant data supporting the ﬁndings are
available from the corresponding author on reasonable request.
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